Female student smiling and sitting in classroom in Africa

Africa's growing vaccine production capacity

Increasing vaccine manufacturing in Africa requires an ecosystem approach and significant investments. Read our latest white paper which outlines barriers, enablers, and recommendations to improve health equity and security by realizing greater vaccine production in Africa.

Hands measuring cough syrup for child patient

Cough syrup contaminants

Deadly contaminants in cough syrup, like diethylene glycol (DEG) and ethylene glycol (EG) have been linked to the deaths of hundreds of children across multiple countries. We developed a free toolkit to help manufacturers and regulators conduct quality testing to protect patients across the globe.

Get the toolkit

Health care worker vaccinating small girl

Technical spotlight: Vaccine access

Routine immunizations provide necessary, long-term protection against many diseases that patients and communities need to thrive. Improving access to quality-assured vaccines can help countries respond to future health emergencies.

Learn more

Webinar: Local Production of Pharmaceuticals

Join us on Monday, February 13 at 8 am EDT for a webinar hosted by the MATRIX collaborative, Local Production of Pharmaceuticals in Sub-Saharan Africa: Is this an Option for Increasing Access to HIV Prevention and MPT Products?

Received this message from a friend? Click here to subscribe.